What Is Cushing’s Syndrome? A Rare Hormonal Disorder with Devastating Health Consequences
ROCHESTER, Minnesota — Cushing syndrome is a serious endocrine disorder caused by prolonged exposure to abnormally high levels of the hormone cortisol, leading to a cascade of debilitating symptoms and life-threatening complications if left untreated, according to leading medical institutions .
The condition, which affects an estimated 3.2 new people per million annually, occurs when the body produces too much cortisol or when patients take glucocorticoid medications for prolonged periods to treat inflammatory conditions such as asthma, rheumatoid arthritis, or lupus . Without treatment, Cushing syndrome can result in characteristic physical changes including a rounded “moon face,” weight gain concentrated in the trunk and upper back with thin arms and legs, easy bruising, and distinctive pink or purple stretch marks on the skin .
“Cushing syndrome is a constellation of clinical manifestations caused by chronic high blood levels of cortisol or related glucocorticoids,” explains the Merck Manual, one of the world’s most widely used medical reference guides . The disorder affects women three to four times more frequently than men, with the average age of onset or diagnosis typically between 20 and 50 years .
Understanding Cortisol: The Body’s Stress Hormone
Cortisol is a hormone produced by the adrenal glands, small organs located on top of each kidney. It plays essential roles in numerous bodily functions, including regulating blood pressure, reducing inflammation, helping the heart and blood vessels function properly, controlling blood sugar levels, and assisting the body in converting food into energy .
The production of cortisol is controlled by a complex feedback system involving the pituitary gland, a pea-sized structure at the base of the brain. The pituitary releases adrenocorticotropic hormone (ACTH), which signals the adrenal glands to produce cortisol. The pituitary then continuously monitors whether the body has the appropriate amount of cortisol and adjusts its signals accordingly .
In healthy individuals, cortisol levels follow a natural daily rhythm, peaking in the early morning hours between 6 and 8 a.m. and gradually declining throughout the day to their lowest point around midnight . Patients with Cushing syndrome lose this normal diurnal variation, maintaining elevated cortisol levels throughout the day and night .
Two Main Types: Exogenous and Endogenous
Medical experts classify Cushing syndrome into two primary categories based on its underlying cause: exogenous (caused by external factors) and endogenous (caused by internal factors) .
Exogenous Cushing Syndrome: Medication-Induced
The most common form of Cushing syndrome is exogenous, resulting from the long-term use of glucocorticoid medications . These drugs, which include prednisone, dexamethasone, and others, are prescribed to treat a wide range of inflammatory and autoimmune conditions such as asthma, rheumatoid arthritis, lupus, inflammatory bowel disease, and to prevent organ rejection after transplantation .
Glucocorticoids can be administered in various forms—orally as pills, by injection, topically as creams or ointments rubbed into the skin, or inhaled through devices such as inhalers for respiratory conditions . Any form of glucocorticoid, if taken in large quantities for an extended period, can potentially trigger the development of Cushing syndrome .
Patients taking these medications should never abruptly discontinue them without medical supervision, as sudden withdrawal can precipitate life-threatening adrenal insufficiency. Instead, physicians typically recommend gradual tapering under close monitoring .
Endogenous Cushing Syndrome: Internal Overproduction
Endogenous Cushing syndrome occurs when the body itself produces excessive cortisol. This can result from several underlying conditions, which are broadly divided into ACTH-dependent and ACTH-independent causes .
ACTH-Dependent Causes account for approximately 80-85 percent of endogenous cases and occur when a tumor produces excessive ACTH, stimulating the adrenal glands to overproduce cortisol. The most common form, known as Cushing disease, results from a benign pituitary tumor (adenoma) that secretes too much ACTH . Cushing disease affects women more frequently than men and represents the most prevalent type of endogenous Cushing syndrome .
A less common ACTH-dependent cause is ectopic ACTH syndrome, in which a tumor outside the pituitary—most frequently in the lungs, pancreas, thyroid, or thymus gland—produces excessive ACTH . These tumors may be cancerous or benign and require different treatment approaches .
ACTH-Independent Causes occur when problems within the adrenal glands themselves lead to autonomous cortisol overproduction. The most common is an adrenal adenoma, a non-cancerous tumor in the outer layer of the adrenal gland that secretes excess cortisol . Adrenocortical carcinoma, a rare cancerous tumor of the adrenal cortex, can also cause Cushing syndrome .
Other rare ACTH-independent causes include primary pigmented nodular adrenal dysplasia, which typically affects adolescents, and bilateral macronodular adrenal hyperplasia, which occurs in older adults . In familial Cushing syndrome, which is extremely rare, individuals inherit a predisposition to develop tumors on one or more endocrine glands, potentially leading to excess cortisol production .
Recognizing the Signs: Physical and Psychological Symptoms
The clinical presentation of Cushing syndrome can vary depending on the level and duration of excess cortisol, but certain characteristic features are highly suggestive of the diagnosis .
Physical Manifestations
The most recognizable physical changes include progressive weight gain concentrated in the trunk of the body while the arms and legs remain relatively slender . Facial rounding, often described as “moon face,” develops along with facial flushing or a plethoric appearance . A characteristic fatty lump, sometimes referred to as a “buffalo hump,” may accumulate between the shoulders in the supraclavicular and dorsal cervical areas .
The skin becomes thin and fragile, bruising easily even with minor trauma, and wounds heal slowly . Wide, reddish-purple stretch marks called striae may appear on the abdomen, hips, thighs, breasts, and underarms . Acne and skin darkening can also occur .
Women frequently experience menstrual irregularities or cessation of periods, along with the growth of thick, dark hair on the face and body—a condition known as hirsutism . Men may experience decreased libido, reduced fertility, and erectile dysfunction .
Systemic Complications
Beyond visible changes, Cushing syndrome wreaks havoc on multiple organ systems. Muscle wasting and weakness, particularly affecting the proximal muscles of the shoulders and thighs, are common . Hypertension develops in many patients, along with glucose intolerance that may progress to type 2 diabetes .
Osteoporosis, or bone loss, significantly increases fracture risk, while kidney stones may form due to altered calcium metabolism . Patients face heightened susceptibility to infections, and venous thromboembolism risk increases nearly sevenfold .
Psychological and Cognitive Effects
The psychological toll of Cushing syndrome is profound and often underrecognized. Major depression affects 50 to 81 percent of patients at diagnosis, while anxiety, irritability, and emotional lability are common . Many patients report difficulty with concentration and memory, insomnia, and emotions that feel difficult to control .
These neuropsychiatric symptoms can persist even after successful treatment, significantly impacting health-related quality of life .
Diagnosis: A Multi-Step Process
Diagnosing Cushing syndrome presents significant challenges due to its gradual onset, diverse symptoms that overlap with common conditions, and complex testing requirements . Diagnosis is often delayed by several years from symptom onset .
The diagnostic approach follows a systematic pathway: screening to confirm hypercortisolism, followed by determination of the underlying etiology .
Initial Screening Tests
First-line testing typically begins with a 24-hour urinary free cortisol measurement, which is elevated in almost all patients with Cushing syndrome . However, levels between 100 and 150 mcg/24 hours may also occur in obesity, depression, or polycystic ovary syndrome without Cushing syndrome . Values exceeding four times the upper limit of normal are considered diagnostic .
The overnight dexamethasone suppression test involves administering 1 mg of dexamethasone orally at 11 p.m. or midnight and measuring serum cortisol at 8 a.m. the following morning. In healthy individuals, this suppresses morning cortisol to below 1.8 mcg/dL, while patients with Cushing syndrome typically show inadequate suppression .
Late-night salivary cortisol measurements take advantage of the lost circadian rhythm in Cushing syndrome. Saliva samples collected at midnight normally contain very low cortisol levels; elevated values strongly suggest the diagnosis .
Determining the Cause
If hypercortisolism is confirmed, plasma ACTH measurement helps distinguish between ACTH-dependent and ACTH-independent causes . Undetectable ACTH levels point to a primary adrenal source, while detectable or elevated levels suggest pituitary or ectopic ACTH production .
For ACTH-dependent cases, additional testing may include the desmopressin stimulation test, in which ACTH and cortisol rise in most patients with pituitary Cushing disease but rarely in those with ectopic sources . Bilateral inferior petrosal sinus sampling, while invasive, provides the most accurate differentiation by measuring ACTH in veins draining the pituitary before and after stimulation .
Imaging studies including pituitary MRI with gadolinium contrast and high-resolution CT of the chest, abdomen, and pelvis help localize potential tumors .
Treatment Approaches: Surgery and Beyond
First-line treatment for endogenous Cushing syndrome is surgical removal of the source of cortisol overproduction . The specific approach depends on the underlying cause.
Surgical Options
For Cushing disease caused by pituitary adenomas, transsphenoidal surgery performed by an expert pituitary surgeon achieves remission rates of 65 to 90 percent . However, relapse occurs in 5 to 36 percent of cases, requiring lifelong monitoring .
Adrenal adenomas or carcinomas are treated with unilateral adrenalectomy, while bilateral adrenalectomy may be necessary for refractory cases or certain forms of adrenal hyperplasia . Ectopic ACTH-producing tumors are surgically removed when feasible .
Medical Therapy
Medical treatment may be necessary for patients who are not surgical candidates, have persistent disease after surgery, or are awaiting the effects of pituitary radiation . Available medications fall into several categories:
Steroidogenesis inhibitors block cortisol production and include ketoconazole, levoketoconazole, metyrapone, osilodrostat, mitotane, and etomidate . These drugs can be administered using either a titration approach—adjusting the dose to normalize cortisol levels—or a block-and-replace strategy using higher doses to suppress endogenous cortisol completely while providing glucocorticoid replacement .
Drugs that modulate pituitary ACTH secretion include pasireotide, a somatostatin analogue, and cabergoline, a dopamine agonist . Mifepristone blocks peripheral glucocorticoid receptors without lowering cortisol levels .
Radiation Therapy
Pituitary radiation may be used for persistent or recurrent Cushing disease after unsuccessful surgery. Its effects are delayed, often taking months to years to achieve remission, during which medical therapy bridges the gap .
Without appropriate treatment, Cushing syndrome carries a mortality risk 3.5 to five times higher than the general population, primarily due to cardiovascular complications and infections . With treatment, many physical changes gradually improve, though some complications may take years to reverse or persist indefinitely .
Health-related quality of life often remains compromised even after biochemical remission, highlighting the need for comprehensive long-term follow-up addressing both physical and psychological sequelae . At diagnosis, 58 to 85 percent of patients have hypertension, 32 to 41 percent are obese, 20 to 47 percent have diabetes mellitus, 31 to 50 percent have osteoporosis, and 38 to 71 percent have dyslipidemia .
The sooner treatment begins, the better the chances for recovery and prevention of irreversible complications. As one medical expert noted: “Cushing syndrome is a rare but devastating disease. Early diagnosis and appropriate treatment are essential to reduce the significant multisystem morbidity and improve long-term outcomes” .
With inputs from:
Healthline: Cushing syndrome symptoms causes
Mayo Clinic: Cushing syndrome diagnosis treatment
NIDDK: Cushing’s syndrome adrenal tumors
NORD: Rare disease Cushing syndrome
Cleveland Clinic: Cushing symptoms treatment
For broader context, see our in-depth analysis on Global Public Health Systems: Policy, Pandemics & Welfare.
Also in this section: Global Public Health Systems: Policy, Pandemics & Welfare.
